Optimizing adjuvant therapy in
EGFR
-mutated non-small cell lung cancer
Ann Transl Med
.
2020 Dec;8(23):1613.
doi: 10.21037/atm-20-3982.
Authors
Annemarie F Shepherd
1
2
,
Isabel R Preeshagul
3
,
Narek Shaverdian
1
,
Abraham J Wu
1
,
Daphna Y Gelblum
1
,
Daniel R Gomez
1
,
Andreas Rimner
1
,
Charles B Simone 2nd
1
2
Affiliations
1
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2
Department of Radiation Oncology, New York Proton Center, New York, NY, USA.
3
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
33437812
PMCID:
PMC7791205
DOI:
10.21037/atm-20-3982
No abstract available
Publication types
Editorial
Comment
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States